The Society for
Functional Precision Medicine

Our Mission

The mission of the Society is to improve patient care and outcomes by facilitating implementation of functional assays into clinical care. The purposes are to foster research and development of functional precision medicine solutions across medicine; to accelerate the dissemination of new and relevant research findings among interested parties; to promote education and training about functional precision medicine; to foster solutions for clinical testing of functional precision medicine approaches; and to improve efficiency of adoption of functional precision medicine solutions through interaction with academia, regulatory bodies, industry, and patients.


Membership

  Become a Member

The SfPM arose out of recognition of the unmet need in matching cancer patients to the therapies best suited for them. Through the use of functional assays, we hope to bridge the gap between patients and the treatments best suited for their cancer. This is possible through research, communication, and collaboration amongst our members and with outreach to the cancer therapy community as a whole. To further the mission, we offer our members the following exclusive benefits

  • SfPM members in good standing (dues paid through Dec. 31, ) are eligible for self nominations in our monthly seminars
  • Exclusive access to our biannual newsletter curated by our board with articles, news and insights about the world of functional precision medicine.
  • A members exclusive directory with information on research interests and home institutions to facilitate collaboration and networking
  • Facilitate trainee placements in post-doc and industry settings by recognizing shared interests and partnerships
  • Free registration for SfPM Annual Meetings and special conferences
  • Access to recordings of our virtual meetings  along with contact information of speakers to connect with
  • Many more ongoing benefits

Applications for membership may be submitted at any time during the year. We look forward to having you onboard!

  Become a Member


Virtual Monthly Seminars

Come join us for our Virtual Monthly Seminar which will bring together a unique mix of pharmaceutical, academic and technology leaders, the series is must attend for those interested in the use of assaying technology to further biomarker discovery, drug R&D and personalized healthcare outcomes.

The Second Wednesday of Each Month - 11:30 AM EST

https://dfci.zoom.us

Meeting ID: 936 9981 1786
Password: 351904

 Learn More   Register

Featured Speakers

Albert Folch, BSc, PhD
Albert Folch, BSc, PhD
University of Washington

“High-Throughput, High-Fidelity Cancer Drug Testing Using Intact Tumor Biopsies”



Recent News

Precision Medicine and Therapeutic Resistance Collection
JUNE 28, 2022
Precision Medicine and Therapeutic Resistance Collection

Check out this great collection of Precision Medicine and Therapeutic Research curated by Cancer Discovery editors selected from the Journal. Some of these select original research articles are followed by their corresponding In the Spotlight commentaries, which serve to place them in the context of their field

Learn More


Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
MARCH 15, 2022
Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia

This February 2020 issue of Cancer Discovery features reports of two very important prospective clinical trials from SFPM members in Zurich, Vienna, Stockholm and Helsinki. Both studies demonstrate the feasibility and utility of functional precision medicine tools in the clinical oncology setting. A commentary by Tony Letai accompanies these articles.

Learn More


Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders
MARCH 15, 2022
Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

This February 2020 issue of Cancer Discovery features reports of two very important prospective clinical trials from SFPM members in Zurich, Vienna, Stockholm and Helsinki. Both studies demonstrate the feasibility and utility of functional precision medicine tools in the clinical oncology setting. A commentary by Tony Letai accompanies these articles.

Learn More


Functional Precision Medicine: Putting Drugs on Patient Cancer Cells and Seeing What Happens
MARCH 15, 2022
Functional Precision Medicine: Putting Drugs on Patient Cancer Cells and Seeing What Happens

This February 2020 issue of Cancer Discovery features reports of two very important prospective clinical trials from SFPM members in Zurich, Vienna, Stockholm and Helsinki. Both studies demonstrate the feasibility and utility of functional precision medicine tools in the clinical oncology setting. A commentary by Tony Letai accompanies these articles.

Learn More


To Test Cancer Drugs, These Scientists Grew ‘Avatars’ of Tumors
MARCH 8, 2022
To Test Cancer Drugs, These Scientists Grew ‘Avatars’ of Tumors

IN 2018, SfPM Member Alana Welm found herself in an exciting, yet burdensome, position. The University of Utah breast cancer research lab where she leads joint projects with her husband, Bryan Welm, had created lab-grown versions of real tumors isolated from living cancer patients. Each cancer had been translated into two kinds of biological models: xenografts, made by implanting tissue into mice, and organoids, miniature clumps of tissue grown in plastic dishes.

Learn More


ALL NEWS